MétaCan
Menu
Back to cohort
Record W4404376147 · doi:10.26685/urncst.697

The Implications of DNMT Mutations and the Prognostic and Therapeutic Relevance of DNMTis in AML: A Literature Review

2024· review· en· W4404376147 on OpenAlexaff
Kaela J. Di Liddo

Bibliographic record

VenueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2024
Typereview
Languageen
FieldMedicine
TopicAcute Myeloid Leukemia Research
Canadian institutionsYork University
Fundersnot available
KeywordsRelevance (law)Clinical significanceGeneticsOncologyPsychologyMedicineInternal medicineBiologyPolitical science

Abstract

fetched live from OpenAlex

Introduction: Acute myeloid leukemia (AML) is a highly heterogeneous and aggressive form of blood cancer characterized by the halted differentiation and proliferation of hematopoietic stem cells (HSCs). Normal hematopoietic functioning is regulated by DNA methyltransferase (DNMT) enzymes which modify the DNA epigenetic landscape. DNMT malfunction is associated with AML, therefore, DNMT inhibitors (DNMTis), such as azacytidine, are being investigated as a potential treatment option for AML patients. This literature review aims to identify the implications of DNMT mutations in AML and the therapeutic value of DNMTis. Methods: A literature search was conducted using databases including the York University library and PubMed using keywords such as “AML”, “DNMT”, “DMNTi”. Studies were restricted to publication dates between 2010 to 2024. Results: DNMT3A mutations, specifically at Arginine 882, are common amongst AML patients. Additionally, ten-eleven translocation methylcytosine dioxygenase 2 (TET2) mutations correlate with AML incidence. Reduced catalytic activity of DNMTs caused by mutations can cause hypomethylation and increased gene transcription or hypermethylation and decreased gene transcription. Depending on the patient genome and responsiveness, DNMTis promote normal cell functioning in malignant cells. Aberrant HSC clonal expansion and proliferation within the bone marrow leads to dysregulated hematopoiesis. This characteristic of AML is correlated with DNMT mutations. Discussion: DNMTis have high therapeutic potential because of their ability to reverse aberrant DNMT methylation patterns while having synergistic effects alongside other treatments. Also, DNA methylation pattern sequencing, such as chromatin accessibility studies, can be useful as predictive biomarkers for AML. The research limitations include navigating the complexity of AML and the variability of responses to DNMTi therapies. Future research should investigate patient biomarkers which could tailor treatment options. Conclusion: The mortality and complexity of AML warrant further investigation into its underlying causes and potential treatments. As a combinatorial and generally well-tolerated treatment, DNMTis are highly promising. Genomic testing that includes methylation level assessment is vital in appropriately detecting biomarkers that can direct patient treatment plans.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.010
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.006
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0100.011
Science and technology studies0.0000.001
Scholarly communication0.0010.002
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.082
GPT teacher head0.486
Teacher spread0.404 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) JournalSame topicAcute Myeloid Leukemia ResearchFrench-language works237,207